Imperial College London Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
University of Nottingham Featured PhD Programmes
10 miles

Queen’s University Belfast, School of Pharmacy Medical / Clinical Science PhD Projects, Programs & Scholarships

We have 13 Queen’s University Belfast, School of Pharmacy Medical / Clinical Science PhD Projects, Programs & Scholarships

  • Medical / Clinical Science×
  • Queen’s University Belfast
  • School of Pharmacy×
  • clear all
Order by 
Showing 1 to 13 of 13
  Antimicrobial prescribing in hospice and palliative care
  Dr C Parsons, Dr D Gilpin
Applications accepted all year round

Funding Type

PhD Type

Terminally ill patients are at high risk of infections and antimicrobial exposure near the end of life. However, the evidence-base to guide prescribers in the use of antibiotics for the treatment of infections in patients receiving hospice and palliative care is currently lacking.
  Determining the microbiome of the homes of people with chronic respiratory diseases
  Dr D Gilpin, Dr D Downey
Application Deadline: 30 June 2020

Funding Type

PhD Type

In recent years, our understanding of the microbial world in and around us has radically changed. The idea that we live with a complex and diverse community of microbes, has moved us away from a “hygiene hypothesis”, where having less bacteria was, to put it simply, better.
  Development and testing of deep learning algorithms to predict pulmonary exacerbations and development of antimicrobial resistance in people with chronic respiratory disease
  Dr M Tunney, Prof JS Elborn
Application Deadline: 30 June 2020

Funding Type

PhD Type

In people with Cystic Fibrosis, acute infective exacerbations or ‘flare-ups’ of chronic respiratory infection are the single most important cause of poor outcome and are associated with increased symptoms, reduced lung function and local and systemic inflammation.
  Dissecting novel mechanisms of cysteine protease biology in tumourigenesis
  Dr R Burden, Prof C Scott
Applications accepted all year round

Funding Type

PhD Type

Proteases are known for their role in facilitating tumour development, primarily through processes such as proliferation and invasion.
  Novel drug delivery systems for Schizophrenia treatment
  Dr E Larraneta
Applications accepted all year round

Funding Type

PhD Type

This PhD project aims to develop, characterise and test a new type of implantable device to provide sustained antipsychotic drug delivery for schizophrenia treatment.
  Optimising pharmacological treatment of non-cognitive symptoms in people with dementia
  Dr H Barry, Prof C Hughes
Applications accepted all year round

Funding Type

PhD Type

Non-cognitive symptoms experienced by people with dementia may include agitation, aggression, distress, psychosis, anxiety and depression.
  Peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention
  Dr G Laverty, Prof K Malcolm
Applications accepted all year round

Funding Type

PhD Type

HIV/AIDS is the leading cause of death in women of reproductive age worldwide. HIV and unintended pregnancies are prevalent in developing nations due to the lack of effective female contraceptive choice.
  Peptide hydrogels as novel nanotherapeutic delivery agents enhancing the anti-tumour efficacy of radiotherapy
  Dr J Coulter, Dr G Laverty
Applications accepted all year round

Funding Type

PhD Type

There is a pressing clinical need for effective localised cancer treatments. Addressing this need we will develop a novel drug delivery system comprised of a nanoparticle/drug releasing hydrogel implant.
  Relationship between antibiotic therapy and development of antimicrobial resistance in patients with bronchiectasis
  Dr M Tunney, Prof JS Elborn
Applications accepted all year round

Funding Type

PhD Type

To decrease the risk of acute infective exacerbations or flare-ups of their condition, individuals with bronchiectasis are frequently prescribed long-term oral and inhaled antibiotics.
  Responsive hydrogel platforms towards the prevention of medical device-associated infections
  Dr N Irwin, Dr C McCoy
Applications accepted all year round

Funding Type

PhD Type

Catheter-associated urinary tract infections represent a high priority global healthcare challenge. We have recently identified a suite of non-antibiotic active agents with promising antibacterial and anti-encrustation activities.
  Surface-modified silicone elastomer for medical and drug delivery devices with reduced bacterial adherence and biofilm formation
  Dr L Carson, Prof K Malcolm
Applications accepted all year round

Funding Type

PhD Type

All implanted medical devices, including those fabricated from silicone elastomers, are susceptible colonisation with communities of microorganisms that colonise the surface of the device and rapidly establish biofilm populations.
  To develop an allosteric inhibitor of HDAC6 inhibition in cancer
  Dr F Furlong, Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

The HDAC6 protein is upregulated in cancer and associated with increased proliferation and metastasis. Several HDAC6 inhibitors have been developed and are in clinical trials.
  USP17 as a cancer therapeutic target
  Dr J Burrows
Applications accepted all year round

Funding Type

PhD Type

USP17 is over-expressed in a range of primary tumours including NSCLC, breast, colorectal, cervical, ovarian and osteosarcoma and its depletion has been shown to block the growth of cells from all these cancer types.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.